Alternative Data for MetLife
About MetLife
MetLife Inc provides life insurance, annuities, employee benefits and asset management in the United States, Japan, Latin America, Asia, Europe and the Middle East.
| Price | $77.36 |
| Target Price | Sign up |
| Volume | 4,160,000 |
| Market Cap | $51.3B |
| Year Range | $72.4 - $82 |
| Dividend Yield | 2.95% |
| PE Ratio | 16.1 |
| Analyst Rating | 91% buy |
| Industry | Insurance |
In the news
Evercore ISI Group Maintains In-Line on MetLife, Lowers Price Target to $95February 10 - Benzinga |
|
 |
5 Insightful Analyst Questions From MetLife’s Q4 Earnings CallFebruary 10 - Yahoo |
|
Half of Retirees Fear Running Out of Money as Pressures on U.S. Retirement Security Intensify, MetLife Research FindsFebruary 9 - Yahoo |
 |
MetLife, Inc. (MET) Presents at Bank of America Financial Services Conference 2026 TranscriptFebruary 9 - SeekingAlpha |
|
MetLife, Inc. 2025 Q4 - Results - Earnings Call PresentationFebruary 8 - SeekingAlpha |
MetLife: Limited Upside Given VII RelianceFebruary 7 - SeekingAlpha |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 23.8B | 18.7B | 5.11B | 771M | 1.38B | 2.490 |
| Q3 '25 | 16.9B | 13.9B | 2.94B | 896M | 1.48B | 2.370 |
| Q2 '25 | 17.2B | 12.6B | 4.54B | 729M | 1.25B | 2.020 |
| Q1 '25 | 18.3B | 13.5B | 4.72B | 945M | 1.61B | 1.960 |
| Q4 '24 | 18.4B | 13.6B | 4.86B | 1.27B | 1.64B | 2.090 |
Insider Transactions View All
| PAPPAS BILL filed to sell 66,744 shares at $80.5. May 13 '25 |
| Khalaf Michel filed to sell 500,799 shares at $82.8. December 17 '24 |
| DEBEL MARLENE filed to sell 108,507 shares at $82.9. December 17 '24 |
| PAPPAS BILL filed to sell 57,768 shares at $72.3. March 20 '24 |
| TADROS RAMY filed to sell 146,981 shares at $71.9. March 14 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
AllstateALL |
$206.56 0.9% | 57 |
 |
ProgressivePGR |
$205.45 1.4% | 64 |
 |
AflacAFL |
$115.88 0.3% | 56 |
 |
LemonadeLMND |
$61.96 9.5% | 66 |
 |
Oscar HealthOSCR |
$13.71 0.8% | 60 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ritchie Torres |
Aug 21, 25 | Sell | $1K - $15K |
| Ro Khanna |
Jul 10, 25 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
Read more about MetLife (MET) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - MetLife
The Market Cap of MetLife is $51.3B.
As of today, MetLife's PE (Price to Earnings) ratio is 16.1.
Currently, the price of one share of MetLife stock is $77.36.
The MET stock price chart above provides a comprehensive visual representation of MetLife's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling MetLife shares. Our platform offers an up-to-date MET stock price chart, along with technical data analysis and alternative data insights.
Yes, MetLife (MET) offers dividends to its shareholders, with a dividend yield of 2.95%. This dividend yield represents MetLife's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering MetLife in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of MetLife are Allstate, Progressive, Aflac, Lemonade, and Oscar Health.
